Syndax Pharmaceuticals Inc (SNDX)
20.45
-0.34
(-1.64%)
USD |
NASDAQ |
Apr 25, 12:07
Syndax Pharmaceuticals Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2021 | 0.0487 |
| September 30, 2021 | 0.1029 |
| June 30, 2021 | 0.0949 |
| March 31, 2021 | 0.0887 |
| December 31, 2020 | 0.0798 |
| September 30, 2020 | 0.1516 |
| June 30, 2020 | 0.1348 |
| March 31, 2020 | 0.3699 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| Date | Value |
|---|---|
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.1155 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Jun 2019
0.3699
Maximum
Mar 2020
0.0974
Average
0.0887
Median
Mar 2021
Debt to Equity Ratio Benchmarks
| SpringWorks Therapeutics Inc | 0.00 |
| Alnylam Pharmaceuticals Inc | -4.626 |
| Geron Corp | 0.3305 |
| Ionis Pharmaceuticals Inc | 3.317 |
| Madrigal Pharmaceuticals Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 612.88M |
| Total Liabilities (Quarterly) | 58.68M |
| Shareholders Equity (Quarterly) | 554.20M |